Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity Systems, CaP Cure, ABC2 Launch Project to Find New Uses for Old Drugs

NEW YORK, April 1 - Ingenuity Systems said today that it is partnering with non-profit foundations ABC2 (Accelerate Brain Cancer Cure) and CaP Cure (Association for the Cure of Cancer of the Prostate) to test existing chemotherapeutic agents against gene defects associated with prostate and brain cancer pathways.

 

Researchers from Cedars-Sinai Medical Center, University of Michigan, University of California, San Francisco, and University of California, Los Angeles, will participate in the program. They will use Ingenuity's Pathways Knowledge Base, a curated model of biological pathways, as well as the company's pathways software, which computationally predicts disease pathways from genomic data.

 

The project aims to better understand which genetic pathways are active in brain and prostate cancer, and which approved or late-stage experimental drugs may disrupt the pathways.

 

"Through a better understanding of how cancer pathways interact, we expect to be able to take existing drugs and in a fraction of the time compared to novel compounds, be able to demonstrate new ways to enhance patient care," said David Agus of Cedars-Sinai Medical Center.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.